Loading…

Loading grant details…

Completed HORIZON European Commission

SWAN: Blitzscaling the early detection of skin cancer

€3.92M EUR

Funder European Commission
Recipient Organization Squaremind
Country France
Start Date Jul 01, 2022
End Date Dec 31, 2024
Duration 914 days
Number of Grantees 1
Roles Coordinator
Data Source European Commission
Grant ID 190119289
Grant Description

Swan is a breakthrough solution to the enduring problem of detecting skin cancer early.

For the first time, Swan enables *full-body* scanning at *dermoscopic* resolution and in less than *3* minutes to the benefit of *all* stakeholders: patients, physicians, hospitals and payers.The solution captures key data that dermatologists acutely need for early diagnosis and brings breakthrough AI triage assistance to flag concerning lesions.

Significant medical time is saved in the process and for patients, the impact is faster access to treatment when needed, fewer unnecessary biopsies and peace of mind.

The solution combines hardware and software and is at the crossroads of cutting-edge, patented technologies in real-time 3D human avatar generation, advanced robotic control, image processing and AI classification of lesions.

Our ambition is to make best-in-class skin cancer screening accessible to everyone, everywhere and finally help dermatology make a quantum leap forward.

All Grantees

Squaremind

Advertisement
Apply for grants with GrantFunds
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant